These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20085425)

  • 21. Strongyloides stercoralis infection in an intestinal transplant recipient.
    Hsu CN; Tseng SH; Chang SW; Chen Y
    Transpl Infect Dis; 2013 Aug; 15(4):E139-43. PubMed ID: 23789974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strongyloides as a cause of fever of unknown origin.
    Neumann I; Ritter R; Mounsey A
    J Am Board Fam Med; 2012; 25(3):390-3. PubMed ID: 22570402
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Mishra S; Patnayak R; Panda SS; Jena A
    J Postgrad Med; 2021; 67(2):113-114. PubMed ID: 33835056
    [No Abstract]   [Full Text] [Related]  

  • 24. Recurrence of strongyloides stercoralis infection in a patient with Hansen's disease: a case report.
    De Souza JN; Machado PR; Teixeira MC; Soares NM
    Lepr Rev; 2014 Mar; 85(1):58-62. PubMed ID: 24974444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary strongyloidiasis.
    Jayaprakash B; Sandhya S; Anithakumari K
    J Assoc Physicians India; 2009 Jul; 57():535-6. PubMed ID: 20329418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periumbilical purpura: challenge and answer. Diagnosis: Strongyloides stercoralis hyperinfection.
    Osio A; Demongeot C; Battistella M; Lhuillier E; Zafrani L; Vignon-Pennamen MD
    Am J Dermatopathol; 2014 Nov; 36(11):899-900, 907. PubMed ID: 25343211
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
    Peters L; McCarthy AE; Faught C
    Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of ivermectin against Strongyloides stercoralis infection in jirds (Meriones unguiculatus).
    Sithithaworn P; Fujimaki Y; Mitsui Y; Prasanthong R; Yutanawiboonchai W; Aoki Y
    Exp Parasitol; 1998 Jun; 89(2):205-12. PubMed ID: 9635444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.
    Buonfrate D; Salas-Coronas J; Muñoz J; Maruri BT; Rodari P; Castelli F; Zammarchi L; Bianchi L; Gobbi F; Cabezas-Fernández T; Requena-Mendez A; Godbole G; Silva R; Romero M; Chiodini PL; Bisoffi Z
    Lancet Infect Dis; 2019 Nov; 19(11):1181-1190. PubMed ID: 31558376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of Strongyloides hyperinfection syndrome in the setting of persistent eosinophilia but negative serology.
    Osiro S; Hamula C; Glaser A; Rana M; Dunn D
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):168-170. PubMed ID: 28377165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infections in dogs.
    Mansfield LS; Schad GA
    J Am Vet Med Assoc; 1992 Sep; 201(5):726-30. PubMed ID: 1399774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
    Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An overview of Strongyloides stercoralis and its infections].
    Ardiç N
    Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Strongyloides stercoralis: a puzzling parasite.
    Luvira V; Watthanakulpanich D; Pittisuttithum P
    Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
    Moura EB; Maia Mde O; Ghazi M; Amorim FF; Pinhati HM
    Braz J Infect Dis; 2012; 16(5):479-81. PubMed ID: 22975175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin.
    Balkhair A; Taher HB; Al Busaidi I; Al Amin M; Al-Khirbash A; Al Adawi B; Al-Siyabi T
    Int J Infect Dis; 2019 Sep; 86():44-46. PubMed ID: 31279610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short report: long-term serum antibody isotype responses to Strongyloides stercoralis filariform antigens in eight patients treated with ivermectin.
    Lindo JF; Atkins NS; Lee MG; Robinson RD; Bundy DA
    Am J Trop Med Hyg; 1996 Nov; 55(5):474-6. PubMed ID: 8940975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strongyloides stercoralis hyperinfection causing eosinophilic ascites.
    Shukla S; Chauhan R; Wadhwa S; Sehgal S; Singh S
    Diagn Cytopathol; 2015 Sep; 43(9):731-3. PubMed ID: 26097138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
    Arch EL; Schaefer JT; Dahiya A
    Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.